ERBB2 and breast carcinoma: One example of a precision medicine test is immunohistochemistry (IHC), such as the test for HER2-overexpression in breast carcinoma that constitutes the key piece of evidence informing a clinical decision to treat a patient with anti-HER2 therapy.